company background image
NEOD logo

NeoDynamics OM:NEOD Stock Report

Last Price

kr0.95

Market Cap

kr31.0m

7D

1.1%

1Y

-98.3%

Updated

29 Apr, 2024

Data

Company Financials +

NEOD Stock Overview

NeoDynamics AB (publ), a medical technology company, engages in the development of biopsy system to enhance diagnostics and treatment of breast cancer patients.

NEOD fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance0/6
Financial Health6/6
Dividends0/6

NeoDynamics AB (publ) Competitors

Price History & Performance

Summary of all time highs, changes and price drops for NeoDynamics
Historical stock prices
Current Share Pricekr0.95
52 Week Highkr62.70
52 Week Lowkr0.85
Beta1.24
1 Month Change0%
3 Month Change-43.45%
1 Year Change-98.31%
3 Year Change-99.67%
5 Year Change-99.77%
Change since IPO-99.81%

Recent News & Updates

Recent updates

Is NeoDynamics (NGM:NEOD) In A Good Position To Invest In Growth?

Mar 18
Is NeoDynamics (NGM:NEOD) In A Good Position To Invest In Growth?

NeoDynamics AB (publ) (NGM:NEOD) Insiders Increased Their Holdings

Dec 03
NeoDynamics AB (publ) (NGM:NEOD) Insiders Increased Their Holdings

Shareholder Returns

NEODSE Medical EquipmentSE Market
7D1.1%1.0%1.1%
1Y-98.3%-8.9%8.6%

Return vs Industry: NEOD underperformed the Swedish Medical Equipment industry which returned -8.9% over the past year.

Return vs Market: NEOD underperformed the Swedish Market which returned 8.6% over the past year.

Price Volatility

Is NEOD's price volatile compared to industry and market?
NEOD volatility
NEOD Average Weekly Movement8.5%
Medical Equipment Industry Average Movement8.1%
Market Average Movement6.2%
10% most volatile stocks in SE Market13.5%
10% least volatile stocks in SE Market3.6%

Stable Share Price: NEOD's share price has been volatile over the past 3 months.

Volatility Over Time: NEOD's weekly volatility has decreased from 18% to 8% over the past year.

About the Company

FoundedEmployeesCEOWebsite
20159Matilda Salenwww.neodynamics.com

NeoDynamics AB (publ), a medical technology company, engages in the development of biopsy system to enhance diagnostics and treatment of breast cancer patients. It develops NeoNavia, a precision biopsy system that offers clinicians and patients accurate lesion targeting and high tissue yield for correct diagnosis and individualized treatment. The company was incorporated in 2015 and is based in Lidingö, Sweden.

NeoDynamics AB (publ) Fundamentals Summary

How do NeoDynamics's earnings and revenue compare to its market cap?
NEOD fundamental statistics
Market capkr30.98m
Earnings (TTM)-kr92.66m
Revenue (TTM)kr751.00k

41.3x

P/S Ratio

-0.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NEOD income statement (TTM)
Revenuekr751.00k
Cost of Revenuekr1.42m
Gross Profit-kr668.00k
Other Expenseskr92.00m
Earnings-kr92.66m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 01, 2024

Earnings per share (EPS)-2.84
Gross Margin-88.95%
Net Profit Margin-12,338.88%
Debt/Equity Ratio0%

How did NEOD perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.